Advanced T cell therapy : current research

This research team belongs to the UMR 1015 - Tumor immunology and immunotherapies

Team website: gustaveroussy.github.io/LaurieMengerLab

Research - Call for Applications 2025

Recruitment of Principal Investigators in Cancer Research

Gustave Roussy and its Foundation are currently seeking applications from both early-career and senior scientists in the field of cancer research.

Villejuif, le 6 novembre 2024

(Epi)genome replication - Publications

• Fajri N, Petryk N^#. Monitoring and quantifying replication fork dynamics with high-throughput methods. Commun Biol. 2024 Jun 14;7(1):729. doi: 10.1038/s42003-024-06412-1.
• Wu X*, Liu Y*, Daubenton-Carafa Y ; Thermes C ; Chen CL#, Hyrien O#, Petryk N#. Genome-wide measurement of DNA replication fork directionality and quantification of DNA replication initiation and termination with Okazaki fragment sequencing. Nature protocols. 2023 Apr;18(4):1260-1295. doi: 10.1038/s41596-022-00793-5.

(Epi)genome replication: research topics

This team belongs to the UMR 9019 Genome Integrity and Cancers.

Our goal is to understand how cells copy both their DNA and epigenome during division. Disruptions in this process can lead to changes in cell identity and contribute to cancer.

Tumour immunology and anti-cancer immunotherapy

The team belongs to the UMR 1015 - Tumour immunology and anti-cancer immunotherapy

The unit "Tumour immunology and anti-cancer immunotherapy" consists of four groups:

Organization of the Biological Resource Center

The Gustave Roussy Biobank is structured into two modules:

Biological Resource Center presentation

The Gustave Roussy Biobank’s mission is to contribute to cancer research by providing research teams with high-quality biological resources.

It has been created in 2001 to centralize the management of biological resources from healthcare and for research purposes, thereby ensuring optimal technical support and traceability of samples and their associated data.

In 2011, the “fluid” module from clinical trials has been integrated into the CRB, expanding the department's scope of activity.

Gustave Roussy est présent au plus grand congrès annuel en cancérologie organisé par l’American Society of Clinical Oncology (ASCO) du 31mai au 4 juin 2024. Ce temps fort rend compte des dernières innovations et résultats de recherche clinique en cancérologie.

Gustave Roussy au congrès de l’ASCO 2024 : une édition particulièrement riche

► Lire l'actualité

Molecular Radiotherapy and Therapeutic Innovation

This team belongs to the UMR 1030 - Molecular radiotherapy and therapeutic innovations

Our team is composed of 2 groups:

• The Cell death, Immunity and Therapeutic Innovation group led by Dr. Jean-Luc PERFETTINI
• The Radiotherapy, ImmunoRadAI group led by Pr. Eric DEUTSCH